Board.Management Changes

IP Group PLC
05 March 2007

For immediate release                                              05 March 2007


                  ('IP Group' or 'the Group' or 'the Company')

                       BOARD & SENIOR MANAGEMENT CHANGES

IP Group plc (LSE: IPO) ('IP Group' or 'the Company' or 'the Group'), the
intellectual property commercialisation company, is delighted to announce that
it has appointed Mike Townend to the Board as Director of Capital Markets with
immediate effect.

Mike, aged 44, has 17 years experience in all aspects of equity capital markets
and was formerly at Lehman Brothers where he was Managing Director, European
Equities and Head of Equity Sales to Hedge Funds. In this role, where he was
jointly responsible for the equity sales operation at Lehman Brothers, Mike
focussed particularly on hedge funds and alternative asset managers and was
responsible for building and maintaining multi strategy and asset class
relationships with institutional investors and prominent alternative asset
managers.

Prior to this, Mike was an Executive Director at Donaldson, Lufkin and Jenrette
('DLJ') where he was recruited to build up business with hedge funds as a key
element of DLJ'S European start up strategy. He has a further eight years equity
sales experience at Banque Paribas and BG Bank where he was Head of Equity
Sales.

In addition, Mike has extensive experience of raising capital, having recently
completed a number of private company fundings including one in the intellectual
property space, Imprimatur Capital.

Separately, IP Group also announces today that Dr Alison Fielding, currently
Director of Technology Transfer, will be assuming an increased role within the
business as Chief Technology Officer. In this role, Alison will be responsible
for all pre-spin-out formation activities across the Group and will also oversee
operations and share and implement best practice.

Dr Bruce Campbell is today stepping down from the Board of Directors. Bruce
has served as Chief Scientific Officer since joining the Board in 2004 and
has contributed enormously to the development of the Group to date. Bruce will
remain involved with the business, serving on the boards of a number of IP Group
portfolio companies.

In addition, IP Group is also pleased to announce the appointment of Dr Rob Rule
to the position of Managing Director of Techtran. IP Group bought Techtran, a
company set up to commercialise university intellectual property under a long
term contract with the University of Leeds, in 2005. Rob, who will be
responsible for the day to day running of Leeds-based Techtran, joins IP Group
from Liverpool Ventures Ltd, an investor in early-stage technology, where he was
Business Director.

Prior to that, Rob was Group Commercial Director of Micap plc where he was
responsible for the commercialisation of the technology licensing business with
global customers in healthcare/pharmaceutical, agrochemical, cosmetics, biocides
and food industries. Rob also has extensive international blue-chip experience
with ICI and DuPont including business management, sales, licensing, marketing,
product development and R&D. Most recently, he was Commercial Manager, DuPont
Polyester Europe where he was responsible for £130 million turnover across
Europe.

The Company confirms that there is no additional information which is required
to be disclosed under Rule 9.6.13 of the Listing Rules of the UK Listing
Authority.

Alan Aubrey, Chief Executive of IP Group, said: 'I would like to thank Bruce
for his immense contribution to the Group and look forward to continuing to work
with him in the future. I would also like to welcome Mike to the Board of IP
Group. Mike's extensive experience both in equity capital markets and in private
company fundings will be invaluable to the Group. I am also delighted that
Alison has agreed to take on an increased role and that Rob has joined
Techtran.'

Mike Townend, IP Group's Director of Capital Markets, said: 'I am delighted to
have the opportunity to apply my banking experience to the creation and
development of some of the UK's most innovative new scientific companies. I'm
also excited to be joining the management team of a ground-breaking business,
which has quickly established itself as the UK's leading IP commercialisation
company, as it moves to the next stage of its development.'

For further information, please contact:

IP Group plc                                      020 7489 5200
Alan Aubrey, Chief Executive Officer
Liz Vaughan-Adams (communications)                020 7489 5206/07979853802

Buchanan
Tim Anderson, Mary-Jane Johnson, Mark Court       020 7466 5000


Notes for Editors

About IP Group

IP Group Plc is an intellectual property (IP) commercialisation company that
specialises in commercialising university technology. Founded in 2001, IP Group
listed on AiM in October 2003 and moved to the Official List in June 2006. It
has made two acquisitions to date - Techtran, a company set up to commercialise
university intellectual property under a long term contract with the University
of Leeds, in 2005 and Top Technology Ventures, an investment adviser to early
stage technology venture capital funds, in 2004.

The group has formed long-term partnerships with ten universities - the
University of Oxford, King's College London, CNAP/University of York, the
University of Leeds, the University of Bristol, the University of Surrey, the
University of Southampton, Queen Mary (University of London), the University of
Bath and the University of Glasgow.

As at 30 June 2006, 44 spin-out companies had been created among the group's
university partners. Of those, eight have listed on the AiM market of the London
Stock Exchange, one on PLUS Markets and there have been two trade sales.

For more information, please visit our website at www.ipgroupplc.com.

                                      ENDS



                      This information is provided by RNS
            The company news service from the London Stock Exchange